They never show any actual financial data at sales meetings. Very suspicious...
That's because most of the company's sales aren't "real" sales. At least, they are not sales that will benefit the bottom line. The company's higher-ups don't want to show that to anyone (internal or external). They may show the number of injectors going out the door, but that's about it.
The company is barely covered by commercial insurance companies, and the majority of "sales" are offset by the kaleo itself. So kaleo is actually covering the most of its patient's pharmacy cost for the injectors. It is hidden in the gross-to-net section of the financials, either through specialty pharmacies or consignment. Most of the revenue that the company earns, that makes it to the bottom line, is from the federal government (medicaid, medicare, VA and DoD).
If you have ever heard a drug commercial that states,,,
" if you you can't afford '
drug name', then '
company name' may be able to help ",,,
or something close to that wording. That is what kaelo is doing, but to a much greater extent than most other drug companies. It can help get medication into the hands of a patient, it doesn't help the bottom line.